FAP and neoplasm: Hence, measures should be taken in future studies to augment tumor responses to FAP-CAR T cells by cooperative killing and combinatorial targeting, for instance, blockade of PD-1 (39–41), combination therapy of dual-target CAR-T both targeting CAFs and tumor cells (29, 42).